Skip to main content
Premium Trial:

Request an Annual Quote

Genaissance to Help Pyxis Track Food Animals

NEW YORK, Oct. 21 (GenomeWeb News) - Genaissance Pharmaceuticals will provide high-throughput genotyping services to Pyxis Genomics, a Chicago-based animal health-services company, the firms said today.


The collaboration addresses an emerging market using genomic technology to document and identify food products throughout the production chain for safety purposes, and to help producers streamline costs.


Terms of the agreement call for Pyxis to pay Genaissance a fee for each test it performs. In addition, the companies will co-commercialize the Pyxis Profile-1 System, a panel of SNPs and related software and databases developed by IBM Life Sciences.


The companies said they have validated the assays to be used in this process, and expect to receive commercial samples.


Further details were not disclosed.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.